Australian and Israeli researchers team up against obesity
24 April, 2012 by Staff WritersScientists from Israel’s Weizmann Institute of Science will be visiting Australia in May to foster and invest in new collaborations with Australian researchers to tackle obesity.
iSonea to trial wheeze diagnostic in children
29 March, 2012 by Dylan Bushell-EmblingiSonea (ASX:ISN) will conduct a post-market trial of its WheezeoMeter diagnostics tool in patients too young for the traditional spirometry method.
Drug cocktail floors malaria
28 March, 2012 by Tim DeanA combination treatment of anti-malarial drugs given intermittently over 12 months can cut malaria infections by up to 30 per cent in infants.
STAT3 gene highlights delicate immune balance
16 March, 2012 by Tim DeanResearchers have found the STAT3 gene is central to proper immune function, raising hope of new medications to treat immunodeficient and autoimmune disorders.
Feature: Getting drug development right
05 March, 2012 by Graeme O'NeillDrug discovery can be enormously expensive when a drug becomes a disaster. Professor Susan Charman’s team is working to fix potential problems early in the drug-development process.
Genome map sheds light on deadly Tasmanian devil tumour
17 February, 2012 by Tim DeanA new genome map reveals the deadly facial tumour afflicting Tasmanian devils shows some unusual genetic properties.
Lorne 2012: Melanoma treatment blasts off
14 February, 2012 by Tim DeanLorne Cancer: The discovery of a key weakness in metastatic melanoma is a Sputnik moment in the treatment of this deadly cancer. Although Professor Richard Kefford thinks we’re still a long way from landing on the moon.
Lorne 2012: Flipping cancer’s switch
13 February, 2012 by Fiona WylieLorne Protein: Dr Nikki Verrills believes reactivating a suppressed protein phosphatase might just switch off leukaemia cells.
Nominations open for Premier’s Award for Health and Medical Research
10 February, 2012 by Staff WritersThe Victorian Premier’s Award for Health and Medical Research is now open for nominations.
WEHI gets $2m grant for new cancer labs
08 February, 2012 by Tim DeanThe Walter and Eliza Hall Institute (WEHI) has received $2 million from the Australian Cancer Research Foundation (ACRF) to fit out two new cancer research laboratories, which will open in late 2012.
Getting to the heart of microRNAs
06 February, 2012 by Tim DeanA new study reveals the diversity of microRNAs present in the heart, giving some insight into cardiac function and disease.
Malaria bigger killer than previously thought
03 February, 2012 by Tim DeanA new study found more than 1.2 million people died from malaria in 2010, although the disease is on the decline thanks to new treatments.
US biosecurity board speaks out on H5N1 concerns
01 February, 2012 by Tim DeanThe US National Science Advisory Board for Biosecurity has explained in detail its rationale in requesting two papers dealing with highly pathogenic H5N1.
Pumping iron raises prospect Parkinson’s and Alzheimer's treatment
30 January, 2012 by Tim DeanResearchers have found a drug that removes excess iron from the brain can prevent Parkinson’s and Alzheimer's disease in mice, raising the prospect of a new treatment.
New skin cancer detection tool approved in Australia
25 January, 2012 by Dylan Bushell-EmblingCanada's Verisante Technology has been cleared by the TGA to sell its instant skin cancer detection tool in Australia.
